Protection or damage: A dual role for the virus-specific cytotoxic T lymphocyte response in hepatitis B and C infection?

Current Opinion in Microbiology

Volumn 3, Issue 4, 2000, Pages 387-392

  Bertoletti, Antonio ^a   Maini, Mala K ^a  

^a ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CELLULAR IMMUNITY; CYTOTOXIC T LYMPHOCYTE; HEPATITIS B; HEPATITIS C; HUMAN; IMMUNOPATHOLOGY; LIVER INJURY; NONHUMAN; REVIEW; VIRUS REPLICATION;

EID: 0033905185     PISSN: 13695274     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1369-5274(00)00109-0     Document Type: Review

References (70)

1. Cytotoxic T cells and viral hepatitis
2. The role of immune responses in the pathogenesis of hepatitis C virus infection
3. Hepatitis B virus immunopathogenesis
4. Pathogenesis of chronic hepatitis C: Immunological features of hepatitis injury and viral persistence
5. Phenotypic analysis of antigen-specific T lymphocytes
6. To kill or to cure: Options in host defense against viral infection
7. Intracellular inactivation of the hepatitis B virus by cytotoxic T lymphocytes
8. Distinct organ-dependent mechanisms for the control of murine cytomegalovirus infection by natural killer cells
9. CD8+ T-cell mediated protection against an intracellular bacterium by perforin-dependent cytotoxicity
10. Noncytopathic clearance of lymphocytic choriomeningitis virus from the hepatocyte
11. Viral clearance without destruction of infected cells during acute HBV infection
12. Essential roles of the Fas ligand in the development of hepatitis
13. Apoptosis and regeneration of hepatocytes during recovery from transient hepadnavirus infections
14. Analysis of a successful-immune response against hepatitis C virus
15. The role of hepatitis C virus-specific cytotoxic T lymphocytes in chronic hepatitis C
16. Direct ex vivo analysis of hepatitis B virus-specific CD8+ T cells associated with the control of infection
17. Quantitative analysis of hepatitis C virus-specific CD8+ T cells in peripheral blood and liver using peptide-MHC tetramers
18. The role of virus-specific CD8+ cells in viral control and liver damage during persistent hepatitis B virus (HBV) infection
19. Human transporter associated with antigen processing (TAPs) select epitope precursor peptides for processing in the endoplasmic reticulum and presentation to T cells
20. Different cytokine profiles of intraphepatic T cells in chronic hepatitis B and hepatitis C virus infections
21. Compartmentalization of T lymphocytes to the site of disease: Intrahepatic CD4+ T cells specific for the protein NS4 of hepatitis C virus in patients with chronic hepatitis C
22. Mechanisms of class I restricted immunopathology. A transgenic mouse model of fulminant hepatitis
23. A T-cell dependent experimental liver injury in mice inducible by concanavalin A
24. Interferon gamma plays a critical role in T cell-dependent liver injury in mice initiated by concanavalin A
25. Contribution of virus-specific CD8+ cytotoxic T cells to virus clearance or pathologic manifestations of influenza virus infection in a T cell receptor transgenic mouse model
26. Role of interferon-gamma in immune cell regulation
27. Protective effect of hepatocyte growth factor on interferon-gamma-induced cytotoxicity in mouse hepatocytes
28. Preferential migration of activated CD4+ and CD8+ T cells in response to MIP-1α and MIP-1β
29. Requirement of MIP-1α for an inflammatory response to viral infection
30. Chemokine and chemokine receptor interactions provide a mechanism for selective T cell recruitment to specific liver compartments within hepatitis C infected liver
31. Early murine cytomegalovirus (MCMV) infection induces liver natural killer (NK) cell inflammation and protection through macrophage inflammatory protein 1α (MIP-1α)-dependent pathways
32. Augmentaion of Vα14 NKT-cell-mediated cytotoxicity by interleukin-4 in an-autocrine mechanism resulting in the development of Concanavalin A-induced hepatitis
33. Chronic active hepatitis in transgenic mice expressing interferon-gamma in the liver
34. Progressive liver injury in chronic hepatitis C infection correlates with increased intrahepatic expression of Th1-associated cytokines
35. Immunopathogenesis of hepatitis B virus recurrence after liver transplantation
36. CD40 activation induces apoptosis in cultured human hepatocytes via induction of cell surface Fas ligand expression and amplifies Fas-mediated hepatocyte death during allograft rejection
37. 'Occult' hepatitis B virus as a source of infection in liver transplant recipients
38. Occult hepatitis B virus infection in patients with chronic hepatitis C liver disease
39. Hepatitis B virus persistence after recovery from acute viral hepatitis
40. Long-lasting memory T cell responses following self-limited acute hepatitis B
41. The hepatitis B virus persists for decades after patients' recovery from acute viral hepatitis despite active maintenance of a cytotoxic T-lymphocyte response
42. Latent hepatitis B virus infection in healthy individuals with antibodies to hepatitis B core antigen
43. Quantification of intrahepatic hepatitis B virus (HBV) DNA in patients with chronic HBV infection
44. Molecular basis for persistent hepatitis B virus infection in the liver after clearance of serum hepatitis B surface antigen
45. Circulating anti-Tax cytotoxic T lymphocytes from human T-cell leukaemia virus type I-infected people, with and without tropical spastic paraparesis, recognize multiple epitopes simultaneously
46. A re-evaluation of the frequency of CD8+ T cells specific for EBV in healthy virus carriers
47. CD8+ T cells can block herpes simplex virus type 1 (HSV-1) reactivation from latency in sensory neurons
48. Population dynamics of immune responses to persistent viruses
49. Natural variants of cytotoxic epitopes are T-cell receptor antagonists for antiviral cytotoxic T cells
50. Hepatitis C virus variants circumventing cytotoxic T lymphocyte activity as a mechanism of chronicity
51. Effects of age and viral determinants on chronicity as an outcome of experimental woodchuck hepatitis virus infection
52. A functional and kinetic comparison of antiviral effector and memory cytotoxic T lymphocyte populations in vivo and in vitro
53. Migration kinetics and final destination of type 1 and type 2 CD8 effector cells predict protection against pulmonary virus infection
54. The cytotoxic T lymphocyte response to multiple hepatitis B virus polymerase epitopes during and after acute viral hepatitis
55. Cellular immune response to hepatitis B virus encoded antigens in acute and chronic hepatitis B virus infection
56. Hepatitis B virus antigen-specific T-cell activation in patients with acute and chronic hepatitis B
57. Different clinical behaviors of acute hepatitis C virus infection are associated with different vigor of the anti-viral cell-mediated immune response
58. Possible mechanism involving T-lymphocyte response to non-structural protein 3 in viral clearance in acute hepatitis C virus infection
59. Recurrence of hepatitis C virus after loss of virus-specific CD4+ T-cell response in acute hepatitis C
60. Hepatitis C virus (HCV) specific immune responses in anti-HCV positive patients with hepatitis C viraemia
61. Dynamics of intra-hepatic lymphocytes in chronic hepatitis C: Enrichment for Vα 24+ T cells and rapid elimination of effector cell by apoptosis
62. Activation and function of natural killer cell responses during viral infections
63. One step ahead of the game: Viral immunomodulatory molecules
64. Modulating chemokines: More lessons from viruses
65. Suppression of host immune response by the core protein of hepatitis C virus: Possible implications for hepatitis C virus persistence
66. Expression of hepatitis C virus proteins inhibits signal transduction through the Jak-STAT pathway
67. Inhibition of interferon-inducible protein kinase PKR by HCV E2 protein
68. Altered helper T lymphocyte function associated with chronic hepatitis B virus infection and its role in response to therapeutic vaccination in humans
69. Lamivudine treatment can restore T cell responsiveness in chronic hepatitis B
70. Immune pathogenesis of hepatocellular carcinoma